Fig. 2: Three-year overall survival and progression-free survival for the entire cohort. | npj Precision Oncology

Fig. 2: Three-year overall survival and progression-free survival for the entire cohort.

From: Personalized circulating tumor DNA dynamics inform survival and response to immune checkpoint blockade in recurrent/metastatic head and neck cancer

Fig. 2

A Overall survival for the entire cohort. B Progression-free survival for the entire cohort. C Overall survival based on ctDNA negativity at any point during the study period based on multivariable analysis. D Progression-free survival based on ctDNA negativity at any point during the study period based on multivariable analysis.

Back to article page